News & Events

On the afternoon of April 18, the Group convened a special session of its Leading Group for the CECEP Yangtze River Economic Belt Pollution Control Main Platform.

Liao Jiasheng and Outside Directors Inspect CECEP Central China Industry Development, General Water of China and CECEP Solar Projects in Zhejiang and Shanghai...

During April 14-17, 2025, Liao Jiasheng, Party Committee Secretary and Chairman of the Group, accompanied by outside directors Lin Wanli, Qi Guosheng, Li Yousheng, Zhou Hougui and Peng Bihong, conducted field research on key projects of subsidiaries in Hangzhou, Huzhou, Jiaxing (Zhejiang) and Shanghai.

Valiant Pharma’s R-PZQ Project Reaches New Milestone

In March 2025, Merck KGaA and the Pediatric Praziquantel Consortium announced that the first preschool-aged child in Uganda has received treatment with Arpraziquantel (R-PZQ) during an implementation study.

212025/04

Group’s Yangtze Pollution Control Platform Holds Special Session

On the afternoon of April 18, the Group convened a special session of its Leading Group for the CECEP Yangtze River Economic Belt Pollution Control Main Platform.

182025/04

Liao Jiasheng and Outside Directors Inspect CECEP Central China Industry Development, General Water of China and CECEP Solar Projects in Zhejiang and Shanghai...

172025/04

Valiant Pharma’s R-PZQ Project Reaches New Milestone

112025/04

CECEP Wind-power ESG Earns CSI Level A Rating

As of the end of March 2025, according to the ESG evaluations released by CSI Primary Industry Public Utilities for 133 listed companies, CECEP Wind-power ranked at Level A.

092025/04

CECEP Intensifies Market-stabilizing Measures with Multi-pronged Approach

CECEP is firmly optimistic about the future of China’s economic development and has always maintained a positive outlook on the prospects of the Chinese capital market.